The proliferation of engineering approaches has accelerated the pace of exploring novel targets against cancer, autoimmune, inflammatory disease, and a range of other indications. The Emerging Targets and Therapeutic Approaches conference will highlight success with improved targeting and innovative solutions to address challenges that remain. Join us this November in Lisbon for a dynamic look at the incredible progress and myriad of solutions that are being investigated to create first-in-class biotherapeutics.

For more details on the conference, please contact:

Gemma Smith
Senior Conference Dircetor
Cambridge Healthtech Institute
Phone: +44 (0)7866.506.196
Email: gsmith@cambridgeinnovationinstitute.com

For sponsorship information, please contact:

Companies A-K
Jason Gerardi
Sr. Manager, Business Development
Cambridge Healthtech Institute
Phone: (+1) 781-972-5452
Email: jgerardi@healthtech.com

Companies L-Z
Ashley Parsons
Manager, Business Development
Cambridge Healthtech Institute
Phone: (+1) 781-972-1340
Email: ashleyparsons@healthtech.com

Conference Programs

• Display of Biologics
• Engineering Antibodies
• Machine Learning Part 2

• Antibody-Based Therapies
• Emerging Targets & Approaches
• Membrane Protein Targets

• Safety & Efficacy of Bispecifics
• Advancing Bispecifics
• Engineering Bispecifics

• Tumour Microenvironment
• Innovations in CAR Therapy
• Next-Gen Immunotherapies

• Optimisation & Developability
• Analytical Characterisation
• Protein Stability & Formulation

• Cell Line Engineering
• Expression Platforms
• Protein Process Development

• Intro to Machine Learning
• Machine Learning: Part 1
• Machine Learning: Part 2

• Intro to Machine Learning
• Intro to Bispecific Antibodies
• Intro to Protein Engineering